硫酸肼（NSC - 150014）治疗癌症患者的试验。 - Suppr

Suppr

超能文献

Trial of hydrazine sulfate (NSC-150014) in patients with cancer.

作者信息

Ochoa M, Wittes R E, Krakoff I H

出版信息

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1151-4.

PMID:769954

Abstract

摘要

相似文献

Trial of hydrazine sulfate (NSC-150014) in patients with cancer.硫酸肼（NSC - 150014）治疗癌症患者的试验。

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1151-4.

Results of clinical study antitumor action of hydrazine sulfate.硫酸肼抗肿瘤作用的临床研究结果

Nutr Cancer. 1981;3(1):7-12. doi: 10.1080/01635588109513694.

Clinical study of hydrazine sulfate in advanced cancer patients.

Cancer Chemother Pharmacol. 1979;3(2):121-4. doi: 10.1007/BF00254983.

Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.对硫酸肼有反应的晚期癌症患者的合成代谢情况。

Nutr Cancer. 1981;3(1):13-9. doi: 10.1080/01635588109513695.

Editorial: Unproven methods of cancer management: hydrazine sulfate.社论：未经证实的癌症治疗方法：硫酸肼。

CA Cancer J Clin. 1976 Mar-Apr;26(2):108-10.

Hydrazine sulfate used in cancer patients.

J Natl Cancer Inst. 1990 Feb 21;82(4):254. doi: 10.1093/jnci/82.4.254.

[The results of a clinical study of the preparation hydrazine sulfate].

Vopr Onkol. 1990;36(6):721-6.

Clinical evaluation of hexamethylmelamine (NSC-13875).

Cancer Chemother Rep. 1973 Feb;57(1):51-8.

Hydrazine sulfate: a current perspective.

Nutr Cancer. 1987;9(2-3):59-66. doi: 10.1080/01635588709513912.

Phase I study of twice weekly 5-azacytidine (NSC-102816).每周两次使用5-氮杂胞苷（NSC-102816）的I期研究。

Cancer Chemother Rep. 1974 Nov-Dec;58(6):895-9.

引用本文的文献

Cancer-Associated Anorexia and Cachexia : Implications for Drug Therapy.癌症相关性厌食和恶病质：对药物治疗的影响。

Drugs. 1992 Apr;43(4):499-506. doi: 10.2165/00003495-199243040-00006.

Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.癌症的非常规疗法：4. 硫酸肼。加拿大乳腺癌研究倡议替代疗法特别工作组。

CMAJ. 1998 May 19;158(10):1327-30.

Is the pharmacological treatment of cancer cachexia possible?癌症恶病质的药物治疗是否可行？

Support Care Cancer. 1993 Nov;1(6):298-304. doi: 10.1007/BF00364967.

Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients.

Invest New Drugs. 1995;13(1):89-97. doi: 10.1007/BF02614227.

Clinical study of hydrazine sulfate in advanced cancer patients.

Cancer Chemother Pharmacol. 1979;3(2):121-4. doi: 10.1007/BF00254983.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验